Previous reports support this assumption: Indeed, iAR-deficient DU145 human prostate cancer cells were shown to overexpress the pro-survival PI-3K/Akt pathway, which was down-regulated following long-term mAR activation [9]. This evidence concerns the gene PTPRN2 and prostate carcinoma.